Literature DB >> 15956266

Neuropsychiatric symptoms and quality of life in Alzheimer disease.

Il-Seon Shin1, Michele Carter, Donna Masterman, Lynn Fairbanks, Jeffrey L Cummings.   

Abstract

OBJECTIVE: Authors examined the impact of neuropsychiatric symptoms in Alzheimer disease (AD) patients' and caregivers' quality of life (QOL) and assessed the relationship of caregiver distress to neuropsychiatric symptoms and caregiver QOL.
METHODS: Sixty-two patients with probable or possible AD and their caregivers participated. Neuropsychiatric symptoms of patients were assessed with the Neuropsychiatric Inventory (NPI). QOL of both patients and caregivers was assessed using the QOL-Alzheimer's Disease (QOL-AD) scale. Each patient and caregiver completed patient QOL ratings; caregivers also completed caregiver QOL assessments.
RESULTS: Caregiver QOL-AD was negatively correlated with agitation/aggression, anxiety, disinhibition, irritability/lability, and total NPI score. Patient QOL on both patient and caregiver ratings was negatively correlated with depression. Patient-reported QOL-AD ratings at different levels of cognitive functioning were not correlated with caregiver-reported ratings. The lack of relationship between patient and caregiver assessments of patient QOL was evident in both mildly and moderately affected patients. Caregiver QOL was negatively correlated with distress related to agitation/aggression, disinhibition, irritability/lability, and total NPI distress.
CONCLUSION: Neuropsychiatric symptoms of AD patients adversely affect both patient and caregiver QOL. These results suggest that identifying and treating neuropsychiatric symptoms in AD may improve both patient and caregiver QOL.

Entities:  

Mesh:

Year:  2005        PMID: 15956266     DOI: 10.1176/appi.ajgp.13.6.469

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  66 in total

Review 1.  Psychotropic medication use for behavioral symptoms of dementia.

Authors:  Philip S Wang; M Alan Brookhart; Soko Setoguchi; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

2.  Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

3.  Anxiety and stigma in dementia: a threat to aging in place.

Authors:  Rebecca J Riley; Sandy Burgener; Kathleen C Buckwalter
Journal:  Nurs Clin North Am       Date:  2014-06       Impact factor: 1.208

4.  Self-reported personality traits are prospectively associated with proxy-reported behavioral and psychological symptoms of dementia at the end of life.

Authors:  Angelina R Sutin; Yannick Stephan; Martina Luchetti; Antonio Terracciano
Journal:  Int J Geriatr Psychiatry       Date:  2017-09-04       Impact factor: 3.485

5.  Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type.

Authors:  Antonio Lobo; Raúl López-Antón; Concepción de-la-Cámara; Miguel Angel Quintanilla; Antonio Campayo; Pedro Saz
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

7.  Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Sue E Leurgans; David A Bennett
Journal:  Arch Neurol       Date:  2009-11

8.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.

Authors:  Els I S Most; Philip Scheltens; Eus J W Van Someren
Journal:  Trials       Date:  2010-02-23       Impact factor: 2.279

9.  Factor structure and invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale.

Authors:  Andrew J Revell; Grace I L Caskie; Sherry L Willis; K Warner Schaie
Journal:  Exp Aging Res       Date:  2009 Apr-Jun       Impact factor: 1.645

10.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.